These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32125255)

  • 41. Implications of pacemakers and implantable cardioverter defibrillators in urological practice.
    Ubee SS; Kasi VS; Bello D; Manikandan R
    J Urol; 2011 Oct; 186(4):1198-205. PubMed ID: 21849189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical safety of the ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 3 T: results of the ProMRI 3T ENHANCED Master study.
    Zbinden R; Wollmann C; Brachmann J; Michaelsen J; Steinwender C; Kovoor P; Kelle S; McGavigan AD; Ching CK; Figtree GA; Schmidt J; Timmel T; Lotz J
    Europace; 2019 Nov; 21(11):1678-1685. PubMed ID: 31322701
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determining the risks of clinically indicated nonthoracic magnetic resonance imaging at 1.5 T for patients with pacemakers and implantable cardioverter-defibrillators: rationale and design of the MagnaSafe Registry.
    Russo RJ
    Am Heart J; 2013 Mar; 165(3):266-72. PubMed ID: 23453091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic Resonance Imaging in Nondependent Pacemaker Patients with Pacemakers and Defibrillators with a Nearly Depleted Battery.
    Okamura H; Padmanabhan D; Watson RE; Dalzell C; Acker N; Jondal M; Romme AL; Cha YM; Asirvatham SJ; Felmlee JP; Friedman PA
    Pacing Clin Electrophysiol; 2017 May; 40(5):476-481. PubMed ID: 28169434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging of implantable cardiac rhythm devices at 3.0 tesla.
    Gimbel JR
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):795-801. PubMed ID: 18684275
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and Quality of 1.5-T MRI in Patients With Conventional and MRI-Conditional Cardiac Implantable Electronic Devices After Implementation of a Standardized Protocol.
    Camacho JC; Moreno CC; Shah AD; Mittal PK; Mengistu A; Lloyd MS; El-Chami MF; Lerakis S; Saindane AM
    AJR Am J Roentgenol; 2016 Sep; 207(3):599-604. PubMed ID: 27304515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical experience of magnetic resonance imaging in patients with cardiac pacing devices: unrestricted patient population.
    Vuorinen AM; Pakarinen S; Jaakkola I; Holmström M; Kivistö S; Kaasalainen T
    Acta Radiol; 2019 Nov; 60(11):1414-1421. PubMed ID: 30781967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short- and long-term electrical performance of the 5086MRI pacing lead.
    Rickard J; Taborsky M; Bello D; Johnson WB; Ramza B; Chang Y; Wilkoff BL
    Heart Rhythm; 2014 Feb; 11(2):222-9. PubMed ID: 24184788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. External electrical cardioversion in patients with cardiac implantable electronic devices: Is it safe and is immediate device interrogation necessary?
    Pluymaekers NAHA; Dudink EAMP; Boersma L; Erküner Ö; Gelissen M; van Dijk V; Wijffels M; Dinh T; Vernooy K; Crijns HJ; Balt J; Luermans JGLM
    Pacing Clin Electrophysiol; 2018 Oct; 41(10):1336-1340. PubMed ID: 30080928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MRI in Adult Patients with Active and Inactive Implanted MR-conditional, MR-nonconditional, and Other Devices.
    Harwood M; Fahrenholtz SJ; Wellnitz CV; Kawashima A; Panda A
    Radiographics; 2024 Mar; 44(3):e230102. PubMed ID: 38421911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnetic resonance imaging at 1.5-T in patients with implantable cardioverter-defibrillators.
    Naehle CP; Strach K; Thomas D; Meyer C; Linhart M; Bitaraf S; Litt H; Schwab JO; Schild H; Sommer T
    J Am Coll Cardiol; 2009 Aug; 54(6):549-55. PubMed ID: 19643318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla.
    Martin ET; Coman JA; Shellock FG; Pulling CC; Fair R; Jenkins K
    J Am Coll Cardiol; 2004 Apr; 43(7):1315-24. PubMed ID: 15063447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and performance of MR-conditional pacing systems with automated MRI mode at 1.5 and 3 Tesla.
    Dacher JN; Langguth P; Adam D; Winkler WB; Martí-Almor J; Prenner G; Trucco ME; Kol A; Xiang M; Melissano D; Fawaz H; Lau DH
    Eur Radiol; 2023 Oct; 33(10):6948-6958. PubMed ID: 37195432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central nervous system MRI and cardiac implantable electronic devices.
    Cadieu R; Peron M; Le Ven F; Kerdraon S; Boutet C; Mansourati J; Ben Salem D
    J Neuroradiol; 2017 Feb; 44(1):1-9. PubMed ID: 27814887
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety of thoracic magnetic resonance imaging for patients with pacemakers and defibrillators.
    Padmanabhan D; Kella DK; Deshmukh AJ; Mulpuru SK; Mehta RA; Dalzell CM; Olson NE; Felmlee JP; Jondal ML; Asirvatham SJ; Watson RE; Cha YM; Friedman PA
    Heart Rhythm; 2019 Nov; 16(11):1645-1651. PubMed ID: 31150818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla.
    Bauer WR; Lau DH; Wollmann C; McGavigan A; Mansourati J; Reiter T; Frömer S; Ladd ME; Quick HH
    Sci Rep; 2019 Dec; 9(1):18243. PubMed ID: 31796767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ectopy in patients with permanent pacemakers and implantable cardioverter-defibrillators undergoing an MRI scan.
    Mollerus M; Albin G; Lipinski M; Lucca J
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):772-8. PubMed ID: 19545340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnetic resonance imaging in non-conditional pacemakers and implantable cardioverter-defibrillators: a systematic review and meta-analysis.
    Munawar DA; Chan JEZ; Emami M; Kadhim K; Khokhar K; O'Shea C; Iwai S; Pitman B; Linz D; Munawar M; Roberts-Thomson K; Young GD; Mahajan R; Sanders P; Lau DH
    Europace; 2020 Feb; 22(2):288-298. PubMed ID: 31995177
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 tesla.
    Nazarian S; Roguin A; Zviman MM; Lardo AC; Dickfeld TL; Calkins H; Weiss RG; Berger RD; Bluemke DA; Halperin HR
    Circulation; 2006 Sep; 114(12):1277-84. PubMed ID: 16966586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immediate and 12 months follow up of function and lead integrity after cranial MRI in 356 patients with conventional cardiac pacemakers.
    Muehling OM; Wakili R; Greif M; von Ziegler F; Morhard D; Brueckmann H; Becker A
    J Cardiovasc Magn Reson; 2014 Jun; 16(1):39. PubMed ID: 24903354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.